hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
Explore linked clinical trials. Standard reference: MONDO:01000831 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder | hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | Recruiting | Early phase 1 | 2026-09-28 | NCT07844694 |